Scientists have developed an interactive web system that, along with your smartphone, can efficiently control your blood pressure.
The participants in the study lowered their blood pressure and were better able to understand how their lifestyle affects their blood pressure.
They also actively participated in follow-up discussions, said the researchers from University of Gothenburg.
"The result showed statistical and clinical significance in lowering blood pressure between the first and last weeks of the study," said Ulrika Bengtsson, PhD student at the Sahlgrenska Academy at Gothenburg University.
Systolic blood pressure (top reading) was lowered by seven mmHg on average and diastolic blood pressure (bottom reading) by 4.9 mmHg. The reduction generally occurred during the first weeks and then stabilised.
"The blood pressure reduction trend was fairly similar, regardless of the initial blood pressure level, blood pressure dropped," Bengtsson added.
In her thesis, Bengtsson developed and evaluated an interactive system for persons living with high blood pressure that, with the help of their own mobile phone, can be used to self-manage the high blood pressure on a daily basis.
The patient reports their blood pressure, pulse, medication intake, lifestyle, symptoms and state of well being in their mobile.
The web system sends questions, individual lifestyle related and encouraging messages and reminders to the patient's mobile.
Graphic feedback is available on the internet allowing the patients and their health care professionals to check blood pressure values in relation to other estimates, either on a specific day or over time.
The results show that the use of the interactive system gave patients a better understanding of the connection between their lifestyle and their blood pressure.
"The patients actively contributed to the followup discussions that were conducted at the end of the study. The discussions primarily addressed how blood pressure can be managed in daily life," Bengtsson noted.
"However, the long-term effects on a larger number of participants should be studied," Bengtsson said in the study that appeared in the Journal of Clinical Hypertension.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
